Analysts Expect Marchex, Inc. (NASDAQ:MCHX) to Announce -$0.10 EPS

Equities analysts expect that Marchex, Inc. (NASDAQ:MCHX) will post earnings of ($0.10) per share for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Marchex’s earnings. Marchex reported earnings per share of ($0.06) in the same quarter last year, which would suggest a negative year over year growth rate of 66.7%. The firm is scheduled to issue its next earnings report on Monday, May 10th.

According to Zacks, analysts expect that Marchex will report full-year earnings of ($0.30) per share for the current fiscal year, with EPS estimates ranging from ($0.31) to ($0.28). For the next year, analysts anticipate that the company will report earnings of ($0.11) per share. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side analysts that follow Marchex.

Marchex (NASDAQ:MCHX) last issued its earnings results on Monday, March 1st. The technology company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.03. The firm had revenue of $12.69 million for the quarter, compared to the consensus estimate of $10.79 million. Marchex had a negative net margin of 31.65% and a negative return on equity of 11.97%.

A number of equities analysts recently issued reports on the stock. Zacks Investment Research downgraded shares of Marchex from a “hold” rating to a “sell” rating in a report on Tuesday, March 9th. Northland Securities reiterated a “buy” rating and set a $4.00 price objective on shares of Marchex in a research note on Wednesday, April 7th. Finally, Roth Capital raised their price objective on Marchex from $3.50 to $4.75 and gave the company a “buy” rating in a research report on Wednesday, February 24th.

MCHX stock traded up $0.20 on Friday, hitting $3.10. The company had a trading volume of 1,520 shares, compared to its average volume of 125,252. The stock has a market cap of $128.05 million, a price-to-earnings ratio of -4.37 and a beta of 1.85. Marchex has a 12-month low of $1.23 and a 12-month high of $3.67. The stock’s 50-day simple moving average is $3.00 and its 200 day simple moving average is $2.51.

In other news, major shareholder Edenbrook Capital, Llc bought 100,000 shares of the business’s stock in a transaction that occurred on Friday, April 9th. The stock was purchased at an average price of $2.80 per share, with a total value of $280,000.00. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. 17.54% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Virtu Financial LLC purchased a new stake in Marchex during the 3rd quarter worth $44,000. Squarepoint Ops LLC acquired a new stake in shares of Marchex during the third quarter valued at about $51,000. Finally, Morgan Stanley increased its position in shares of Marchex by 416.5% during the third quarter. Morgan Stanley now owns 76,623 shares of the technology company’s stock worth $163,000 after acquiring an additional 61,789 shares during the last quarter. Institutional investors own 66.28% of the company’s stock.

About Marchex

Marchex, Inc operates as a call analytics company that helps businesses connect, drive, measure, and convert callers into customers. Its products include Marchex Call Analytics, an analytics platform for enterprises that depend on inbound phone calls to drive sales, appointments, and reservations; Marchex Speech Analytics that enable actionable insights for enterprise, mid-sized, and small businesses; Text Analytics and Communications, which enable businesses to send and receive text/SMS messages with customers; Call Monitoring; and Marchex Sales Edge that enable businesses to understand customer conversations in phone calls and text.

See Also: Which market index is the best?

Get a free copy of the Zacks research report on Marchex (MCHX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Marchex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marchex and related companies with MarketBeat.com's FREE daily email newsletter.